SISRAM MED (01696) announced its interim results, with the loss attributable to shareholders of the parent company amounting to $1.155 million, a shift from profit to loss compared to the same period last year.
Furuixi Medical Technology (01696) announced its interim results for 2026, with revenue of approximately $171.4 million, an increase of 3.6% year-on-year. The loss attributable to equity holders of the parent company was $1.155 million, a turnaround from profit to loss compared to the same period last year; the loss per share was 0.25 cents.
SISRAM MED (01696) announced its mid-term results for 2026, with revenues of approximately $171.4 million, an increase of 3.6% year-on-year. The loss attributable to shareholders of the parent company was $1.155 million, turning from profit to loss year-on-year; the loss per share was 0.25 cents.
Related Articles
ZJLD (06979) announced its interim results, with an adjusted net profit of 626 million yuan, an increase of 2.1% year-on-year.

YUES INTL HLDG (01529) appoints Xiao Wentao as executive director.

KINGSOFT CLOUD (03896) AI cloud continues to make breakthroughs as Xiaomi and Kingsoft accelerate the growth of their ecological businesses both internally and externally.
ZJLD (06979) announced its interim results, with an adjusted net profit of 626 million yuan, an increase of 2.1% year-on-year.
YUES INTL HLDG (01529) appoints Xiao Wentao as executive director.

KINGSOFT CLOUD (03896) AI cloud continues to make breakthroughs as Xiaomi and Kingsoft accelerate the growth of their ecological businesses both internally and externally.

RECOMMEND





